PALSONIFY 30 mg/1
PALTUSOTINE · TABLET, FILM COATED · Crinetics Pharmaceuticals, Inc.
No Recall History
Plain English
PALSONIFY is a tablet, film coated containing paltusotine at 30 mg/1, taken oral. Manufactured by Crinetics Pharmaceuticals, Inc..
Key Facts
- Brand Name
- PALSONIFY
- Generic Name
- PALTUSOTINE
- NDC Code (Product)
84015-930- Manufacturer
- Crinetics Pharmaceuticals, Inc.
- Strength
- 30 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA219070
- Marketing Start
- 09/25/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is PALSONIFY used for?
PALSONIFY contains PALTUSOTINE. It is a tablet, film coated taken oral. Consult your doctor for specific uses.
Is PALSONIFY a controlled substance?
PALSONIFY is not classified as a controlled substance by the DEA.
What is the generic name for PALSONIFY?
The generic name for PALSONIFY is PALTUSOTINE. There are no other listed brand versions of PALTUSOTINE.
What is the NDC code for PALSONIFY 30 mg/1?
The NDC (National Drug Code) for PALSONIFY 30 mg/1 is 84015-930, listed by Crinetics Pharmaceuticals, Inc..
Other PALSONIFY Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)